Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 4:01 PM View:  | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Conversion | 1,179,530 | -- | -- | 100% 1.18M to 2.36M | |
| 01-Oct-24 4:01 PM View: | Bioage Labs, Inc. (BIOA) | 27-Sep-24 | Purchase | 450,000 | $18.00 | $8,100,000.00 | 19% 2.36M to 2.81M | |
| 24-Sep-24 4:04 PM View: | Corbus Pharmaceuticals Hold... (CRBP) | 20-Sep-24 | Purchase | 350,000 | $20.01 | $7,003,760.00 | 17% 2.02M to 2.38M | |
| 08-May-24 4:23 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 06-May-24 | Market Purchase | 850,000 | $11.86 | $10,081,700.00 | 11% 7.47M to 8.32M | 6% |
| 22-Apr-24 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 18-Apr-24 | Purchase | 581,765 | $18.03 | $10,489,400.00 | 8% 6.89M to 7.47M | |
| 03-Apr-24 5:37 PM View: | Immuneering Corp (IMRX) | 01-Apr-24 | Sale | 400,000 | $2.90 | $1,160,180.00 | (2%) 26.36M to 25.96M | |
| 18-Mar-24 5:59 PM View: | Immuneering Corp (IMRX) | 15-Mar-24 | Sale | 400,000 | $2.14 | $856,400.00 | (2%) 18.72M to 18.32M | |
| 18-Mar-24 5:59 PM View: | Immuneering Corp (IMRX) | 14-Mar-24 | Sale | 509,091 | $3.72 | $1,892,600.00 | (3%) 19.23M to 18.72M | |
| 11-Mar-24 5:34 PM View: | Corbus Pharmaceuticals Hold... (CRBP) | 08-Mar-24 | Purchase | 300,000 | $44.38 | $13,314,200.00 | 17% 1.73M to 2.02M | |
| 11-Mar-24 5:34 PM View: | Corbus Pharmaceuticals Hold... (CRBP) | 07-Mar-24 | Purchase | 250,000 | $40.05 | $10,013,400.00 | 17% 1.48M to 1.73M | |
| 06-Feb-24 4:00 PM View: | Corbus Pharmaceuticals Hold... (CRBP) | 02-Feb-24 | Purchase | 750,000 | $19.00 | $14,250,000.00 | 103% 725.0K to 1.48M | |
| 30-Jan-24 4:23 PM View: | Corbus Pharmaceuticals Hold... (CRBP) | 26-Jan-24 | Purchase | 282,632 | $32.24 | $9,111,940.00 | 64% 442.37K to 725.0K | |
| 11-Jan-24 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 11-Jan-24 | Purchase | 750,000 | $19.75 | $14,812,500.00 | 12% 6.14M to 6.89M | |
| 11-Jan-24 4:00 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Jan-24 | Purchase | 105,000 | $21.32 | $2,238,600.00 | 2% 6.04M to 6.14M | |
| 12-Dec-23 4:52 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 08-Dec-23 | Purchase | 588,235 | $17.00 | $10,000,000.00 | 11% 5.45M to 6.04M | |
| 06-Dec-23 4:39 PM View: | Eyepoint Pharmaceuticals, I... (EYPT) | 04-Dec-23 | Purchase | 1,919,060 | $21.82 | $41,874,200.00 | 54% 3.53M to 5.45M | |
| 25-Oct-23 4:15 PM View: | Ambrx Biopharma, Inc. (AMAM) | 23-Oct-23 | Purchase | 1,307,310 | $6.99 | $9,139,540.00 | 13% 9.92M to 11.23M | |
| 19-Sep-23 4:49 PM View: | Ambrx Biopharma Inc. (AMAM) | 18-Sep-23 | Purchase | 751,233 | $9.24 | $6,944,920.00 | < 1% 137.43M to 138.18M | |
| 19-Sep-23 4:49 PM View: | Ambrx Biopharma Inc. (AMAM) | 15-Sep-23 | Purchase | 1,401,500 | $9.05 | $12,680,700.00 | 1% 136.03M to 137.43M | |
| 24-Jul-23 4:01 PM View: | Greenlight Biosciences Hold... (GRNA) | 20-Jul-23 | Sale | 9,188,660 | -- | -- | (100%) 9.19M to 0 | |
| 20-Apr-23 6:04 PM View: | Ambrx Biopharma Inc. (AMAM) | 20-Apr-23 | Purchase | 886,634 | $11.60 | $10,285,200.00 | < 1% 198.33M to 199.21M | |
| 20-Apr-23 6:04 PM View: | Ambrx Biopharma Inc. (AMAM) | 19-Apr-23 | Purchase | 951,909 | $11.15 | $10,612,400.00 | < 1% 197.38M to 198.33M | |
| 20-Apr-23 6:04 PM View: | Ambrx Biopharma Inc. (AMAM) | 18-Apr-23 | Purchase | 3,376,650 | $11.27 | $38,053,100.00 | 2% 194.0M to 197.38M | |
| 17-Apr-23 5:46 PM View: | Ambrx Biopharma Inc. (AMAM) | 17-Apr-23 | Purchase | 562,121 | $10.67 | $5,999,460.00 | < 1% 183.76M to 184.33M | |
| 17-Apr-23 5:46 PM View: | Ambrx Biopharma Inc. (AMAM) | 14-Apr-23 | Purchase | 841,967 | $9.96 | $8,384,310.00 | < 1% 182.92M to 183.76M | |
| 17-Apr-23 5:46 PM View: | Ambrx Biopharma Inc. (AMAM) | 13-Apr-23 | Purchase | 1,193,810 | $9.16 | $10,935,500.00 | < 1% 181.73M to 182.92M | |
| 16-Mar-23 10:00 PM View: | Ambrx Biopharma Inc. (AMAM) | 16-Mar-23 | Purchase | 500,000 | $10.15 | $5,074,250.00 | < 1% 158.75M to 159.25M | |
| 16-Mar-23 10:00 PM View: | Ambrx Biopharma Inc. (AMAM) | 15-Mar-23 | Purchase | 250,000 | $10.60 | $2,648,880.00 | < 1% 158.5M to 158.75M | |
| 16-Mar-23 10:00 PM View: | Ambrx Biopharma Inc. (AMAM) | 14-Mar-23 | Purchase | 250,000 | $9.95 | $2,488,280.00 | < 1% 158.25M to 158.5M | |
| 13-Jan-22 4:06 PM View: | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 616,786 | -- | -- | 100% 0 to 616.79K | |
| 27-Oct-21 4:04 PM View: | Ventyx Biosciences, Inc. (VTYX) | 25-Oct-21 | Conversion | 785,303 | -- | -- | 100% 785.31K to 1.57M | |
| 27-Oct-21 4:04 PM View: | Ventyx Biosciences, Inc. (VTYX) | 25-Oct-21 | Private Purchase | 625,000 | $16.00 | $10,000,000.00 | 40% 1.57M to 2.2M | |
| 15-Oct-21 4:12 PM View: | Pyxis Oncology, Inc. (PYXS) | 13-Oct-21 | Conversion | 668,854 | -- | -- | 100% 668.86K to 1.34M | |
| 15-Oct-21 4:12 PM View: | Pyxis Oncology, Inc. (PYXS) | 13-Oct-21 | Purchase | 450,000 | $16.00 | $7,200,000.00 | 34% 1.34M to 1.79M | |
| 21-Sep-21 10:00 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Sep-21 | Conversion | 757,432 | -- | -- | 100% 757.43K to 1.51M | |
| 21-Sep-21 10:00 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Sep-21 | Private Purchase | 312,500 | $16.00 | $5,000,000.00 | 21% 1.51M to 1.83M | |
| 05-Aug-21 10:00 PM View: | Immuneering Corp (IMRX) | 03-Aug-21 | Conversion | 1,702,630 | -- | -- | 100% 1.7M to 3.41M | |
| 05-Aug-21 10:00 PM View: | Immuneering Corp (IMRX) | 03-Aug-21 | Private Purchase | 550,000 | $15.00 | $8,250,000.00 | 16% 3.41M to 3.96M | |
| 07-Jul-21 4:45 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 02-Jul-21 | Conversion | 1,530,690 | -- | -- | 100% 1.53M to 3.06M | |
| 07-Jul-21 4:45 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 02-Jul-21 | Purchase | 500,000 | $14.00 | $7,000,000.00 | 16% 3.06M to 3.56M | |
| 30-Jun-21 4:08 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 2,602,200 | -- | -- | 100% 2.6M to 5.2M | |
| 30-Jun-21 4:08 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase | 600,000 | $19.00 | $11,400,000.00 | 12% 5.2M to 5.8M | |
| 23-Jun-21 4:02 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Conversion Duplicate | 709,224 | -- | -- | 100% 709.23K to 1.42M | |
| 23-Jun-21 4:02 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Private Purchase | 275,000 | $19.00 | $5,225,000.00 | 19% 1.42M to 1.69M | |
| 29-Apr-21 4:02 PM View: | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Conversion | 2,326,660 | -- | -- | 100% 2.33M to 4.65M | |
| 29-Apr-21 4:02 PM View: | Rain Oncology Inc. (RAIN) | 27-Apr-21 | Market Purchase | 450,000 | $17.00 | $7,650,000.00 | 10% 4.65M to 5.1M | |
| 01-Apr-21 4:15 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Conversion | 4,364,840 | -- | -- | 100% 4.36M to 8.73M | |
| 01-Apr-21 4:15 PM View: | Design Therapeutics, Inc. (DSGN) | 30-Mar-21 | Purchase | 750,000 | $20.00 | $15,000,000.00 | 9% 8.73M to 9.48M | |
| 18-Mar-21 4:43 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Mar-21 | Conversion | 1,848,020 | -- | -- | 100% 1.85M to 3.7M | |
| 18-Mar-21 4:43 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Mar-21 | Purchase | 375,000 | $19.00 | $7,125,000.00 | 10% 3.7M to 4.07M |